Results 11 to 20 of about 3,146 (147)

Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models [PDF]

open access: yesFrontiers in Immunology, 2018
Complement is essential for the protection against infections; however, dysregulation of complement activation can cause onset and progression of numerous inflammatory diseases.
Seline A. Zwarthoff   +8 more
doaj   +4 more sources

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases [PDF]

open access: yesFrontiers in Immunology, 2019
C3 glomerulopathy (C3G) is a severe kidney disease, which is caused by defective regulation of the alternative complement pathway. Disease pathogenesis is heterogeneous and is caused by both autoimmune and genetic factors.
Fei Zhao   +13 more
doaj   +2 more sources

A novel and rapid method to purify the human complement opsonin C3b from human plasma [PDF]

open access: yesFrontiers in Immunology
Complement opsonin C3b is at the center of the complement cascade. All complement initiation pathways converge when convertases activate C3, converting it into the anaphylatoxin C3a and the opsonin C3b, which can attach to surfaces via its freshly ...
Jannik Sichau, Christoph Q. Schmidt
doaj   +2 more sources

C3 glomerulonephritis with genetically confirmed C3 deficiency in a pediatric patient: a case report [PDF]

open access: yesChildhood Kidney Diseases
Complement component 3 glomerulonephritis (C3GN) is a rare kidney disease characterized by complement dysregulation that results in prominent complement component 3 (C3) deposition in the kidneys. The clinical course of C3GN varies from mild hematuria to
Hae Min Kim   +8 more
doaj   +2 more sources

Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia. [PDF]

open access: yesPLoS ONE, 2014
OBJECTIVES: Paroxysmal nocturnal hemoglobinemia (PNH) is a rare but serious condition characterized by complement-mediated red blood cell (RBC) hemolysis and episodic thrombotic attack.
Moonhee Lee   +3 more
doaj   +1 more source

Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase. [PDF]

open access: yesProceedings of the National Academy of Sciences, 1981
The unique specificity of monoclonal antibodies (Ab) was combined with the cell-killing function of the cytolytic alternative pathway of complement. The functionally C3b-like glycoprotein of cobra venom was linked to a murine monoclonal Ab directed to a human melanoma-associated antigen by a disulfide bond, by using a heterobifunctional crosslinking ...
C W, Vogel, H J, Müller-Eberhard
openaire   +2 more sources

Adventitial Niches, Complement and Inflammation in Pulmonary Vascular Disease: Current Status and Future Directions. [PDF]

open access: yesCompr Physiol
Local complement production by pulmonary artery adventitial fibroblasts, activated intracellularly by CFD and CFB and extracellularly by GZMK+ CD8 T cells, and its secretion in soluble form and within EVs promotes macrophage and T cell chemotaxis and activation.
Zhang H   +9 more
europepmc   +2 more sources

Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces

open access: yesFrontiers in Immunology, 2021
To discriminate between self and non-self surfaces and facilitate immune surveillance, the complement system relies on the interplay between surface-directed activators and regulators.
Arthur Dopler   +10 more
doaj   +1 more source

A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia–reperfusion injury

open access: yesScientific Reports, 2021
The complement system is a potent mediator of ischemia–reperfusion injury (IRI), which detrimentally affects the function and survival of transplanted kidneys.
Anjan K. Bongoni   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy